Effect of osteopontin on TIMP-1 and TIMP-2 mRNA in chondrocytes of human knee osteoarthritis in vitro
Authors:
Open Access
- 29 May 2014
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 8 (2) , 391-394
Abstract
Tissue inhibitors of metalloproteinases (TIMPs) regulate the activity of matrix metalloproteinases (MMPs) and enzymes from the a disintegrin and metalloproteinase domain with thrombospondin motifs family in osteoarthritis (OA). Elevated osteopontin (OPN) levels in plasma, synovial fluid and articular cartilage are associated with progressive OA joint damage; however, the role of OPN in the pathological changes of knee OA remains undetermined. The present study was undertaken to examine the effect of OPN on the expression of TIMP-1 and TIMP-2 mRNA in chondrocytes from 16 patients with knee OA. In this study, following the stimulation of human chondrocytes with recombinant human OPN (rhOPN; 100 ng/ml and 1 μg/ml, respectively) for 48 h, MTT assay was used to determine cell viability while the quantitative polymerase chain reaction (PCR) was used to detect the alterations in TIMP-1 and TIMP-2 levels. The results illustrated that neither 100 ng/ml nor 1 μg/ml rhOPN caused cytotoxicity or apoptosis of chondrocytes and that the relative mRNA expression of TIMP-1 and TIMP-2 was significantly increased in the 1 μg/ml rhOPN group compared with that in the control group (P=0.022 and P=0.003, respectively). However, no significant difference in expression was revealed between the 100 ng/ml rhOPN and control groups (P=0.998 and P=0.209, respectively). In conclusion, OPN may have a protective effect against pathological changes in advanced-stage OA.Keywords
This publication has 19 references indexed in Scilit:
- Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patientsOsteoarthritis and Cartilage, 2010
- Accelerated development of aging‐associated and instability‐induced osteoarthritis in osteopontin‐deficient miceArthritis & Rheumatism, 2009
- Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritisClinical Biochemistry, 2009
- Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritisOsteoarthritis and Cartilage, 2001
- Osteopontin: An intrinsic inhibitor of inflammation in cartilageArthritis & Rheumatism, 2001
- Differential Expression of Aggrecanase and Matrix Metalloproteinase Activity in Chondrocytes Isolated from Bovine and Porcine Articular CartilageJournal of Biological Chemistry, 1998
- Biochemical Characterization of Human Collagenase-3Journal of Biological Chemistry, 1996
- High‐resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibiaThe Anatomical Record, 1992
- Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritisArthritis & Rheumatism, 1990
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989